Neogenomics (NEO) Cash from Financing Activities (2010 - 2026)
Neogenomics' (NEO) quarterly Cash from Financing Activities came in at -$12.2 million in Q2 2026, up 93.95% on a YoY basis from -$6.3 million in Q2 2025, and down 3522.49% quarter-over-quarter from -$338000.0 in Q1 2026.
Neogenomics (NEO) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has reported Cash from Financing Activities for 17 consecutive years, with -$12.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities rose 93.95% year-over-year to -$12.2 million; the trailing twelve-month figure through Jun 2026 stood at -$11.4 million (up 94.3% YoY), and the FY2025 full-year result was -$200.3 million, down 4410.98% from the prior year.
- Cash from Financing Activities fell to -$12.2 million in Q2 2026 per NEO's latest filing, from -$338000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $6.1 million in Q1 2022 and bottomed at -$202.4 million in Q2 2025.
- Historically, Cash from Financing Activities has averaged -$10.7 million across 5 years, with a median of $980000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 2971.88% in 2024, then slumped 10396.69% in 2025.
- Over 5 years, Cash from Financing Activities stood at $1.8 million in 2022, then retreated by 29.52% to $1.3 million in 2023, then slumped by 45.91% to $687000.0 in 2024, then slumped by 37.26% to $431000.0 in 2025, then slumped by 2940.84% to -$12.2 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$12.2 million, -$338000.0, and $431000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 12.21 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | -229.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -919.90 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 23.01 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 97.12 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -36.90 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | -2.41 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 6.09 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 142.19 Mn |
| 10 | Neogenomics | 2.55 Bn | 2.40 Bn | 91.88 Mn | -12.24 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.24 Mn |
| Mar 31, 2026 | -338,000.00 |
| Dec 31, 2025 | 431,000.00 |
| Sep 30, 2025 | 765,000.00 |
| Jun 30, 2025 | -202.43 Mn |
| Mar 31, 2025 | 949,000.00 |
| Dec 31, 2024 | 687,000.00 |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 816,000.00 |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | 2.96 Mn |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 6.06 Mn |
| Dec 31, 2021 | 2.46 Mn |
| Sep 30, 2021 | -6.72 Mn |
Neogenomics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NEO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "NEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();